Dimethylformamide → HCID 71626459, 화합물

반응식

[CH3:1][C:2]1([CH3:19])[CH2:14][C:13]2=[N:15][NH:16][C:17](=[O:18])[C:10]3[C:11]4[C:12]2=C(NC=4[CH:7]=[CH:8][CH:9]=3)[CH2:3]1.[H-].[Na+].[CH3:22]I.[CH3:24][N:25]([CH:27]=O)[CH3:26]>>[CH3:1][C:2]1([CH3:19])[CH2:14][C:13]2=[N:15][N:16]([CH3:22])[C:17](=[O:18])[C:10]3[C:11]4[C:12]2=[C:27]([N:25]([CH3:24])[C:26]=4[CH:7]=[CH:8][CH:9]=3)[CH2:3]1

참가 물질

반응물 4

HCID 6228Dimethylformamide

HCID 6328Methyl iodide

HCID 24758Sodium hydride

HCID 136242904HCID 136242904, 화합물

생성물 1

HCID 71626459HCID 71626459, 화합물수율 95%

실험 절차

The desired product was prepared using a procedure similar to step 1 of Example 22. Subsequently, 2,2-dimethyl-2,3,5,10-tetrahydro-[1,2]diazepino[3,4,5,6-def]carbazol-6(1H)-one (0.02 g, 0.08 mmol) was reacted with NaH (2.4 mg, 0.1 mmol) and methyl iodide (0.06 g, 0.4 mmol) in DMF (2 ml) to give the desired product (20 mg, 95%) as yellow solid. 1H NMR (DMSO-d6) δ 7.51-7.55 (m, 2H), 7.16 (t, 1H, J=7.8 Hz), 3.69 (s, 3H), 3.42 (s, 3H), 2.72 (s, 2H), 2.27 (s, 2H), and 1.09 (s, 6H). MS (ESI) m/e [M+1]+ 282.